Human CDKN1B/CDKN4/KIP1 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_004064.4)
Cat. No.: pGMPC000041
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CDKN1B/CDKN4/KIP1 Non-Viral expression plasmid (overexpression vector) for mouse CDKN1B overexpression in unique cell transient transfection and stable cell line development.
Go to
P27/KIP1/CDKN1B/CDKN1B/CDKN4 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC000041 |
| Gene Name | CDKN1B |
| Accession Number | NM_004064.4 |
| Gene ID | 1027 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 597 bp |
| Gene Alias | CDKN4,KIP1,MEN1B,MEN4,P27KIP1 |
| Fluorescent Reporter | Firefly luciferase |
| Mammalian Cell Selection | Null |
| Fusion Tag | Null |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTCAAACGTGCGAGTGTCTAACGGGAGCCCTAGCCTGGAGCGGATGGACGCCAGGCAGGCGGAGCACCCCAAGCCCTCGGCCTGCAGGAACCTCTTCGGCCCGGTGGACCACGAAGAGTTAACCCGGGACTTGGAGAAGCACTGCAGAGACATGGAAGAGGCGAGCCAGCGCAAGTGGAATTTCGATTTTCAGAATCACAAACCCCTAGAGGGCAAGTACGAGTGGCAAGAGGTGGAGAAGGGCAGCTTGCCCGAGTTCTACTACAGACCCCCGCGGCCCCCCAAAGGTGCCTGCAAGGTGCCGGCGCAGGAGAGCCAGGATGTCAGCGGGAGCCGCCCGGCGGCGCCTTTAATTGGGGCTCCGGCTAACTCTGAGGACACGCATTTGGTGGACCCAAAGACTGATCCGTCGGACAGCCAGACGGGGTTAGCGGAGCAATGCGCAGGAATAAGGAAGCGACCTGCAACCGACGATTCTTCTACTCAAAACAAAAGAGCCAACAGAACAGAAGAAAATGTTTCAGACGGTTCCCCAAATGCCGGTTCTGTGGAGCAGACGCCCAAGAAGCCTGGCCTCAGAAGACGTCAAACGTAA |
| ORF Protein Sequence | MSNVRVSNGSPSLERMDARQAEHPKPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSLPEFYYRPPRPPKGACKVPAQESQDVSGSRPAAPLIGAPANSEDTHLVDPKTDPSDSQTGLAEQCAGIRKRPATDDSSTQNKRANRTEENVSDGSPNAGSVEQTPKKPGLRRRQT |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T14006-Ab | Anti-CDKN1B monoclonal antibody |
| Target Antigen | GM-Tg-g-T14006-Ag | CDKN1B protein |
| ORF Viral Vector | pGMLP003982 | Human CDKN1B Lentivirus plasmid |
| ORF Viral Vector | pGMPC000041 | Human CDKN1B Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP003982 | Human CDKN1B Lentivirus particle |
Target information
| Target ID | GM-T14006 |
| Target Name | P27/KIP1/CDKN1B |
|
Gene Group Identifier (Target Gene ID in Homo species) |
1027 |
| Gene ID |
1027 (Homo sapiens), 111773925 (Equus caballus), 12576 (Mus musculus), 403429 (Canis lupus familiaris) 493958 (Felis catus), 512613 (Bos taurus), 697188 (Macaca mulatta), 83571 (Rattus norvegicus) |
| Gene Symbols & Synonyms | CDKN1B,Cdkn1b,KIP1,MEN4,CDKN4,MEN1B,P27KIP1,p27,Kip1,p27Kip1,Cdki1b |
| Target Alternative Names | CDKN1B,CDKN4,Cdki1b,Cdkn1b,Cyclin-dependent kinase inhibitor 1B,Cyclin-dependent kinase inhibitor p27,KIP1,Kip1,MEN1B,MEN4,P27,P27KIP1,p27,p27Kip1 |
| Uniprot Accession |
O19001,P46414,P46527,Q6SLL5
Additional SwissProt Accessions: P46527,P46414,Q6SLL5,O19001 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Endocrine resistance, ErbB signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Cushing syndrome, Measles, Human papillomavirus infection, Epstein-Barr virus infection, Pathways in cancer, Prostate cancer, Chronic myeloid leukemia, Small cell lung cancer, Gastric cancer |
| Gene Ensembl | ENSG00000111276, ENSMUSG00000003031, ENSCAFG00845023770, ENSBTAG00000018254, ENSMMUG00000050457 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


